Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Benjamin Halladay > Profile

Benjamin Halladay

Affiliations

  • Chief Financial Officer at Esperion Therapeutics Inc. (ESPR), 2025-03-19
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Esperion Therapeutics Inc.
 ESPR $1.48 3,535 Officer 481,710 2025-03-18 Filing
Esperion Therapeutics Inc.
 ESPR $1.86 11 Officer 240,671 2025-02-19 Filing
Esperion Therapeutics Inc.
 ESPR $2.27 9 Officer 240,682 2025-01-17 Filing
Esperion Therapeutics Inc.
 ESPR $2.42 3,245 Officer 240,691 2024-12-17 Filing